Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
What should marketing and medical affairs invest in for Q4?
Join Jade and Isabel as they explore the critical trends that have shaped the industry in 2024 and what teams should leverage in Q4.
Read more
Season 5 highlights: GOLD Medal Moments
As Season 5 of the GOLD podcast approaches its end, join Isabel and Jade as they share some of the most memorable moments from the last couple of months.
Meeting customer needs in medical affairs
Uncover the latest customer expectations of medical affairs in this episode of the GOLD podcast, which sees the team speak with not one but two medical affairs leaders from top healthcare consultancy firm, ZS.
Translating policy into action
In this episode, Jade picks the brains of Anita Ralli, Director, Government Affairs, Inclusion and Diversity, Employee Resource Group Lead, Gilead Sciences UK to find out how companies can attract diverse talent to their workforce.
Meet GOLD’s new catalyst – CSL Behring’s Karen Pinachyan
In this week’s episode, Isabel and Jade share some snippets from the interview with GOLD’s next catalyst Karen Pinachyan, Head of Medical Affairs, Europe, CSL Behring.
Shaping success in cell therapy
Navigate the evolving landscape of cell therapy with hosts Isabel and Jade as they present an insightful discussion with Warner Biddle, Senior Vice President and Global Head of Commercial, Kite, a Gilead Company.
Pharma, Pride and the LGBTQ+ community
This week, the GOLD team looks into how the industry can support patients and staff in the LGBTQ+ community.
What will it take to transform cancer care?
In this episode, Isabel discusses with Dr Sunil Verma, Global Head of Oncology, Medical, AstraZeneca about his passion for working in oncology.
Powering the new commercial model
Tune in to the next episode of the GOLD podcast to hear the team’s latest conversation with a leading figure in the pharmaceutical industry. What is being discussed this week? The industry’s evolving commercial model.
Loading posts...
« Previous
1
…
3
4
5
6
7
…
23
Next »